MIT engineers have quietly solved one of the biggest bottlenecks in living-tissue robotics, creating synthetic tendons that ...
According to management, statistical assessments of the Phase 3 trial points to a very high probability of technical success for regulatory approval of ateganosine. The U.S. Food and Drug ...
Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...
At the Carnegie Global Technology Summit 2025, Changmin Lee, Chief Technology Officer, iSciLab Cooperation, says, "Our ...
LNK01006 recently received IND clearance from the FDA to initiate first-in-human studies in the US. Formation Bio plans to initiate a Phase 1 study in the first half of 2026, reflecting the company's ...
Aspens and standing dead trees, which are important to forest biodiversity, can be reliably identified from openly available ...